MEGAN MILLER: Open Payments
NPI 1740849645 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 7 companies in 2025. Trend: 2023 $215 · 2024 $160 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 1 | $33 |
| Fresenius USA Marketing, Inc. | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| AKEBIA THERAPEUTICS INC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: IBSRELA, VELPHORO, TARPEYO, Empaveli, Vafseo, BENLYSTA.
Industry payments across MO — which companies pay providers there.
